AQP2 Gene Diabetes Insipidus Nephrogenic Autosomal NGS Genetic DNA Test
Comprehensive Genetic Analysis for Nephrogenic Diabetes Insipidus
The AQP2 Gene Diabetes Insipidus Nephrogenic Autosomal NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for water balance disorders. This advanced test specifically targets mutations in the AQP2 (Aquaporin-2) gene, which plays a critical role in kidney water reabsorption and maintaining proper fluid balance in the body.
What This Test Measures and Detects
Our state-of-the-art NGS Genetic DNA Test comprehensively analyzes the AQP2 gene to identify:
- Pathogenic variants in the AQP2 gene coding regions
- Autosomal recessive inheritance patterns
- Specific mutations affecting aquaporin-2 water channel function
- Genetic markers associated with nephrogenic diabetes insipidus
- Novel variants that may impact treatment response
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Excessive thirst (polydipsia) and frequent urination (polyuria)
- Family history of nephrogenic diabetes insipidus
- Unexplained dehydration episodes despite adequate fluid intake
- Children with failure to thrive and recurrent dehydration
- Patients with suspected hereditary kidney disorders
- Individuals planning pregnancy with family history of water balance disorders
Key Benefits of AQP2 Genetic Testing
- Definitive Diagnosis: Provides conclusive genetic evidence for nephrogenic diabetes insipidus
- Personalized Treatment: Enables targeted therapeutic approaches based on specific genetic mutations
- Family Planning Guidance: Offers crucial information for genetic counseling and reproductive decisions
- Early Intervention: Facilitates prompt management to prevent complications
- Comprehensive Analysis: Utilizes advanced NGS technology for thorough genetic assessment
Understanding Your Test Results
Our genetic specialists provide detailed interpretation of your AQP2 gene analysis:
- Positive Result: Indicates presence of pathogenic AQP2 gene mutations confirming nephrogenic diabetes insipidus diagnosis
- Negative Result: Suggests absence of detectable AQP2 mutations, though clinical correlation is essential
- Variant of Uncertain Significance: Requires additional family studies and clinical evaluation
- Carrier Status: Identifies individuals who may pass the condition to offspring
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have comprehensive testing facilities across the United States, serving patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more locations.
Take Control of Your Genetic Health Today
Don’t let uncertainty about hereditary conditions affect your quality of life. Our AQP2 Gene Diabetes Insipidus Nephrogenic Autosomal NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results delivered within 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood on FTA card, getting tested has never been more convenient.
Book your genetic test now by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward understanding your genetic health and ensuring proper management of potential hereditary conditions.
